Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cost burden resulting from post-surgical complications caused by aesthetic surgery abroad: A retrospective two-center experience.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Stromal Vascular Fraction Across Different Clinical Indications: A Pro-Regenerative <i>Fil Rouge</i>.

Journal of clinical medicine·2026
Same author

Venous Thromboembolism After Pedicled TRAM Versus Free Flap Breast Reconstruction: A Propensity-Matched Analysis.

Clinical breast cancer·2026
Same author

Re-Vision of Geometric Flap Design in Lower Limb Reconstruction: A Comparative Analysis on Perforator Enhancement.

Journal of clinical medicine·2026
Same author

Preoperative detection of perforating vessels in autologous abdominal flap-based breast reconstruction using a smartphone-based thermography device.

JPRAS open·2025
Same author

Systemic Administration of Tranexamic Acid Improves Postoperative Outcome in Abdominoplasty.

Journal of clinical medicine·2025
Same journal

Eugene Braunwald, MD, 1929-2026.

Circulation·2026
Same journal

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Circulation·2026
Same journal

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Circulation·2026
Same journal

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Circulation·2026
Same journal

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same journal

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
See all related articles

Related Experiment Video

Updated: Jul 5, 2026

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique
10:11

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

Cardiac allograft vasculopathy: recent developments.

Daniel Schmauss1, Michael Weis

  • 1Medizinische Klinik und Poliklinik I, University Hospital Munich-Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany.

Circulation
|April 23, 2008
PubMed
Summary
This summary is machine-generated.

Cardiac allograft vasculopathy (CAV) hinders long-term heart transplant success. Early detection via intravascular ultrasound and improved immunosuppression show promise, but personalized immune monitoring is crucial for prevention.

More Related Videos

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
08:32

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Published on: December 4, 2010

Related Experiment Videos

Last Updated: Jul 5, 2026

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique
10:11

Murine Cervical Aortic Transplantation Model using a Modified Non-Suture Cuff Technique

Published on: November 2, 2019

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
08:32

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Published on: December 4, 2010

Area of Science:

  • Cardiology
  • Immunology
  • Transplantation Science

Background:

  • Cardiac allograft vasculopathy (CAV) is a major limitation in heart transplant recipients.
  • CAV pathogenesis involves complex innate and adaptive immune responses, alongside non-immune insults like ischemia-reperfusion and metabolic disorders.
  • Impaired vascular repair mechanisms contribute significantly to CAV development.

Purpose of the Study:

  • To review the current understanding of CAV pathogenesis, detection, and management.
  • To highlight the role of immune responses in CAV development and progression.
  • To discuss emerging strategies for CAV prevention and the need for individualized therapeutic approaches.

Main Methods:

  • Literature review focusing on recent insights into CAV pathogenesis and treatment.
  • Analysis of diagnostic methods, emphasizing intravascular ultrasound (IVUS) for early detection.
  • Evaluation of current and investigational therapeutic strategies, including immunosuppressants, statins, and novel prevention methods.

Main Results:

  • Intravascular ultrasound is the most sensitive method for CAV detection; progressive intimal thickening within the first year predicts high cardiovascular event risk.
  • Improved immunosuppressive agents (mycophenolate mofetil, proliferation signal inhibitors) and statins demonstrate beneficial effects on CAV progression.
  • Coronary revascularization offers only palliative treatment for CAV without improving long-term survival.

Conclusions:

  • Routine noninvasive imaging for CAV detection during follow-up is encouraged.
  • Personalized immune monitoring and therapeutic modulation are essential due to dynamic changes in recipient immune responses to allografts.
  • Future research directions include growth factor inhibition, cell therapy, and tolerance induction for CAV prevention.